BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30389290)

  • 21. Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis.
    Zeng X; She P; Zhou L; Li S; Hussain Z; Chen L; Wu Y
    Microbiologyopen; 2021 Jan; 10(1):e1148. PubMed ID: 33345466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penfluridol overcomes paclitaxel resistance in metastatic breast cancer.
    Gupta N; Gupta P; Srivastava SK
    Sci Rep; 2019 Mar; 9(1):5066. PubMed ID: 30911062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth.
    Hu J; Cao J; Jin R; Zhang B; Topatana W; Juengpanich S; Li S; Chen T; Lu Z; Cai X; Chen M
    Cell Commun Signal; 2022 Jul; 20(1):105. PubMed ID: 35842652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin.
    Hait WN; Gesmonde JF; Lazo JS
    Anticancer Res; 1994; 14(5A):1711-21. PubMed ID: 7531409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of growth and of thymidine incorporation into DNA in Tetrahymena by chlorpromazine, pimozide and penfluridol.
    Keegan FP; Blum JJ
    J Protozool; 1983 May; 30(2):397-402. PubMed ID: 6415270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.
    Hedrick E; Li X; Safe S
    Mol Cancer Ther; 2017 Jan; 16(1):205-216. PubMed ID: 27811009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of penfluridol and chlorpromazine in the treatment of chronic schizophrenia.
    Wang RI; Larson C; Treul SJ
    J Clin Pharmacol; 1982; 22(5-6):236-42. PubMed ID: 7107969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled study of penfluridol in the treatment of chronic schizophrenia.
    Lapierre YD
    Am J Psychiatry; 1978 Aug; 135(8):956-9. PubMed ID: 665841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer.
    Lai TC; Lee YL; Lee WJ; Hung WY; Cheng GZ; Chen JQ; Hsiao M; Chien MH; Chang JH
    Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penfluridol: a long-acting oral neuroleptic. A controlled study.
    Kurland AA; Ota KY; Slotnick VB
    J Clin Pharmacol; 1975; 15(8-9):611-21. PubMed ID: 1097478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
    Enyeart JJ; Biagi BA; Mlinar B
    Mol Pharmacol; 1992 Aug; 42(2):364-72. PubMed ID: 1355264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral long acting antipsychotic penfluridol as a harm reduction treatment in a patient suffering from untreated schizophrenia and multiple drug dependence: A case report.
    Dauré C; Fortias M; Icick R; Delage C; Bloch V; Avril E; Vorspan F
    Psychiatry Res; 2021 Oct; 304():114147. PubMed ID: 34371297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological studies of antipsychotic drug, penfluridol. 2. General pharmacological properties].
    Ito K; Nurimoto S; Ochiai T; Horiuchi M; Suzuki S
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):501-17. PubMed ID: 1033105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: Chlorpromazine Versus Penfluridol for Schizophrenia.
    Pich J
    Issues Ment Health Nurs; 2018 Sep; 39(9):814-815. PubMed ID: 30252565
    [No Abstract]   [Full Text] [Related]  

  • 36. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.
    Greer YE; Gilbert SF; Gril B; Narwal R; Peacock Brooks DL; Tice DA; Steeg PS; Lipkowitz S
    Breast Cancer Res; 2019 Feb; 21(1):27. PubMed ID: 30777098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
    Ranjan A; German N; Mikelis C; Srivenugopal K; Srivastava SK
    Tumour Biol; 2017 Jun; 39(6):1010428317705517. PubMed ID: 28618969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CRISPR/Cas9-Based Screening for Non-Homologous End Joining Inhibitors Reveals Ouabain and Penfluridol as Radiosensitizers.
    Du J; Shang J; Chen F; Zhang Y; Yin N; Xie T; Zhang H; Yu J; Liu F
    Mol Cancer Ther; 2018 Feb; 17(2):419-431. PubMed ID: 28864683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics.
    Quitkin F; Rifkin A; Kane J; Ramos-Lorenzi JR; Klein DF
    Arch Gen Psychiatry; 1978 Jul; 35(7):889-92. PubMed ID: 98127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential value of penfluridol and pipothiazine palmitate.
    Gallant DM
    Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.